Evidence map›Paper›PMID 31673250›Full record

ArticleDose-response : a publication of International Hormesis Society

Wei Sun, Guifu He, Mingming Zhang, Yi Zhao, Hongmei Yu, Yi Li, Wei Wu, Tiefeng Ji

Open access · goldAbstract read
In one paragraph

Article in Dose-response : a publication of International Hormesis Society. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 83% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Wei SunInstitute of Pediatrics, First Hospital, Jilin University, Changchun, Jilin, China.ORCID https://orcid.org/0000-0003-0260-4484
Guifu HeDepartment of Nuclear Medicine, Jilin Provincial Tumor Hospital, Changchun, Jilin, China.
Mingming ZhangDepartment of Molecular Biology, College of Basic Medical Sciences, Jilin University, Changchun, Jilin, China.
Yi ZhaoDepartment of Nuclear Medicine, Jilin Provincial Tumor Hospital, Changchun, Jilin, China.
Hongmei YuDepartment of Blood Transfusion, China-Japan Union Hospital, Jilin University, Changchun, Jilin, China.
Yi LiState Key Laboratory of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin University, Changchun, Jilin, China.
Wei WuDepartment of Nuclear Medicine, Jilin Provincial Tumor Hospital, Changchun, Jilin, China.
Tiefeng JiDepartment of Radiology, First Hospital, Jilin University, Changchun, Jilin, China.
Jilin University · CNJilin Province Tumor Hospital · CNUnion Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsOur study was designed to investigate the usefulness of

methods

resultIn

conclusionIt's demonstrated that the

Indexed as

99mTc-3PRGD2antiangiogeniccisplatinendostar

Identifiers

PMID31673250
PMCPMC6804356
OpenAlexW2980668378

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.